CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.24% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
NIOX Group PLC (LSE: NIOX) is a medical diagnostics company specialising in asthma management through its NIOX® FeNO testing technology. The company’s devices help clinicians measure airway inflammation, enabling more accurate diagnosis and personalised treatment. With increasing global demand for respiratory health solutions, NIOX Group is well-positioned to expand in both clinical and research markets.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.